Correlation Between DiaMedica Therapeutics and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Design Therapeutics.
Diversification Opportunities for DiaMedica Therapeutics and Design Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between DiaMedica and Design is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Design Therapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Design Therapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to under-perform the Design Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, DiaMedica Therapeutics is 1.02 times less risky than Design Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Design Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 357.00 in Design Therapeutics on January 26, 2024 and sell it today you would earn a total of 8.00 from holding Design Therapeutics or generate 2.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Design Therapeutics
Performance |
Timeline |
DiaMedica Therapeutics |
Design Therapeutics |
DiaMedica Therapeutics and Design Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Design Therapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase TherapeuticsInc | DiaMedica Therapeutics vs. Oncolytics Biotech |
Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |